Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
951723

Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020
Published: | GlobalData | 48 Pages | Delivery time: 1-2 business days

Price

Back to Top
Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020
Published: July 30, 2020
GlobalData
Content info: 48 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring.

Scope

  • Global epidemiology metrics and trends
  • Snapshot of epidemiological trends to date in the top three most-affected countries
  • An overview of the pipeline for antivirals and vaccines
  • Summary of available efficacy data
  • An assessment of the clinical trials landscape by phase, sponsor type, geography, and other key attributes
  • Highlights in deal-making trends, particularly public-private partnerships
  • Spotlight on social media coverage

Reasons to Buy

  • Understand the global epidemiology of COVID-19
  • Obtain a snapshot of epidemiological trends to date in the top three most-affected countries
  • Access an overview of the pipeline for therapeutics and vaccines
  • Stay up to date on available efficacy data for pipeline-stage products
  • View the clinical trials landscape by across key attributes
  • Get up to speed on highlights in deal-making trends, particularly public-private partnerships
  • Monitor top trends in social media coverage
Product Code: GDHCHT113

Table of Contents

Table of Contents

1 Executive Summary

  • 1.1 Report Scope
  • 1.2 Navigate the COVID-19 Outbreak with GlobalData Pharma's COVID-19 Dashboard
  • 1.3 Monitor the COVID-19 Outbreak with GlobalData Epidemiology Indicators

2 Epidemiology

  • 2.1 Epidemiology: Snapshot as of March 25, 2020
  • 2.2 Epidemiology: Disease Trajectory as of March 25, 2020
  • 2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020
  • 2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020
  • 2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020
  • 2.6 Epidemiology Forecast: United States

3 Pipeline Overview

  • 3.1 Pipeline Therapeutics: Breakdown by Phase
  • 3.2 Pipeline Therapeutics: Breakdown by Molecule Type
  • 3.3 Pipeline Therapeutics: Breakdown by Type of Developer
  • 3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
  • 3.5 Pipeline Therapeutics: Preclinical-Stage Candidates
  • 3.6 Pipeline Therapeutics: Currently Available Data
  • 3.7 Pipeline Vaccines: Breakdown by Phase
  • 3.8 Pipeline Vaccines: Breakdown by Developer Type
  • 3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

4 Pipeline Overview

  • 4.1 Pipeline Therapeutics: Breakdown by Phase
  • 4.2 Pipeline Therapeutics: Breakdown by Molecule Type
  • 4.3 Pipeline Therapeutics: Breakdown by Type of Developer
  • 4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
  • 4.5 Pipeline Therapeutics: Preclinical-Stage Candidates
  • 4.6 Pipeline Therapeutics: Currently Available Data
  • 4.7 Pipeline Vaccines: Breakdown by Phase
  • 4.8 Pipeline Vaccines: Breakdown by Developer Type
  • 4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

5 Clinical Trials

  • 5.1 Clinical Trials: Breakdown by Phase
  • 5.2 Clinical Trials for Therapeutics and Vaccines
  • 5.3 Clinical Trials: Overview by Region
  • 5.4 Clinical Trials for Therapeutics: Leading Sponsors
  • 5.5 Clinical Trials: Leading Industry Sponsors
  • 5.6 Trends in Trial Design

6 Deal-making Trends

  • 6.1 Deal-making Trends

7 Social Media Trends

  • 7.1 Key Twitter Chatter
  • 7.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

8 Key Findings

  • 8.1 Key Findings

9 Appendix

  • 9.1 Sources
  • 9.2 Methodology
  • 9.3 About the Authors

10 About GlobalData

  • 10.1 Contact Us